ArticleCureus2026
Acrometastasis as an Initial Sign of Progression in Untreated Metastatic Renal Cell Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acral metastases are an exceptionally uncommon manifestation of bone dissemination, with renal cell carcinoma (RCC) serving as a particularly rare primary source. Historically, these lesions signified terminal disease managed with palliative amputation, although most data predate modern immunotherapy. A man in his 50s presented with newly diagnosed clear cell RCC, an inferior vena cava tumor thrombus, and bilateral lung metastases. He repeatedly declined systemic immunotherapy. Nine months later, he developed a painful swelling of the right ring fingertip. Imaging revealed an osteolytic lesion of the distal phalanx. Amputation was performed, and histopathology confirmed metastatic RCC. This case illustrates an atypical acral metastasis secondary to untreated, naturally progressing systemic disease. It highlights the challenges of patient autonomy and traditional medicine preferences. It emphasizes the role of local surgery for symptom relief and histological verification and underscores the necessity of a highly individualized, multidisciplinary approach to managing rare metastatic presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.